Photodynamic therapy for childhood choroidal neovascular membrane associated with best's vitelliform dystrophy.
Subfoveal choroidal neovascular membrane is an uncommon cause of visual impairment in children and that caused secondary to Best's disease is a well-known entity. However, limited experience exists in treatment of such lesions in the pediatric age group. This report describes the outcomes of treatment in three such eyes. Three eyes of two children were treated with Verteporfin photodynamic therapy. One patient was observed up to 23 months and the other for up to 2 years. All three eyes were stabilized with a fair to good visual recovery. No ocular or systemic side effects were noted. Verteporfin photodynamic therapy may be a considered treatment option for childhood choroidal neovascular membranes secondary to Best's disease.